UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 68

Sortiert nach

The Value of Neutrophil-to-Lymphocyte Ratio to Identify Bacterial Infection and Predict Short-Term Mortality in Patients with Acutely Decompensated Cirrhosis

Diagnostics (Basel), 2023-09, Vol.13 (18), p.2954

2023

Volltextzugriff (PDF)

Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value

Autoimmunity reviews, 2023-07, Vol.22 (7), p.103356, Article 103356

2023

Volltextzugriff (PDF)

Patient‐reported quality of care in primary sclerosing cholangitis

Liver international, 2023-08, Vol.43 (8), p.1654-1662

2023

Volltextzugriff (PDF)

A DNA pool of FLT3-ITD positive DNA samples can be used efficiently for analytical evaluation of NGS-based FLT3-ITD quantitation - Testing several different ITD sequences and rates, simultaneously

Journal of biotechnology, 2019-09, Vol.303, p.25-29

2019

Volltextzugriff (PDF)

Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis

World journal of gastroenterology : WJG, 2017-08, Vol.23 (29), p.5412-5421

2017

Volltextzugriff (PDF)

Presepsin teardown- pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis

World journal of gastroenterology : WJG, 2016-11, Vol.22 (41), p.9172-9185

2016

Volltextzugriff (PDF)

Emerging medical therapies for severe alcoholic hepatitis

Clinical and Molecular Hepatology, 2020, 26(4), , pp.686-696

2020

Volltextzugriff (PDF)

Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study

BMC gastroenterology, 2021-03, Vol.21 (1), p.94-94, Article 94

2021

Volltextzugriff (PDF)

MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease

Gastroenterology (New York, N.Y. 1943), 2018-01, Vol.154 (1), p.238-252.e7

2018

Volltextzugriff (PDF)

Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic Hepatitis

Hepatology (Baltimore, Md.), 2019-10, Vol.70 (4), p.1134-1149

2019

Volltextzugriff (PDF)

Editorial: serologic antibodies in primary sclerosing cholangitis – a tell‐tale sign of compromised gut‐liver immunity?

Alimentary pharmacology & therapeutics, 2021-01, Vol.53 (2), p.350-351

2021

Volltextzugriff (PDF)

Emerging medical therapies for severe alcoholic hepatitis

Clinical and molecular hepatology, 2020-10, Vol.26 (4), p.686-696

2020

Volltextzugriff (PDF)

Serological biomarkers for management of primary sclerosing cholangitis

World journal of gastroenterology : WJG, 2022-06, Vol.28 (21), p.2291-2301

2022

Volltextzugriff (PDF)

Sa1676 Soluble CD163 (sCD163) Is a Marker of Infection in Patients With Cirrhosis and Acute Decompensation and an Independent Predictor of the Short-Term Mortality

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-1009-S-1009

2015

Volltextzugriff (PDF)

Neutrophil extracellular traps contribute to liver damage and increase defective low-density neutrophils in alcohol-associated hepatitis

Journal of hepatology, 2023-01, Vol.78 (1), p.28-44

2023

Volltextzugriff (PDF)

THU-106-YI Prospective european reference network registry (R-LIVER) supports improvement in bone disease care delivery at local level for patients with autoimmune liver diseases and enables detailed description of risk elements

Journal of hepatology, 2024-06, Vol.80, p.S313-S313

2024

Volltextzugriff (PDF)

Serum villin-1 level-a tell-tale sign of gut barrier failure in patients with cirrhosis and acute decompensation

Journal of hepatology, 2023-06, Vol.78, p.S25

2023

Volltextzugriff (PDF)

OS-017-YI - Serum villin-1 level-a tell-tale sign of gut barrier failure in patients with cirrhosis and acute decompensation

Journal of hepatology, 2023-06, Vol.78, p.S25-S25

2023

Volltextzugriff (PDF)

Phenotypic polymorphism of haptoglobin: A novel risk factor for the development of infection in liver cirrhosis

Human immunology, 2011-04, Vol.72 (4), p.348-354

2011

Volltextzugriff (PDF)

Non-pancreatic hyperlipasemia: A puzzling clinical entity

World journal of gastroenterology : WJG, 2024-05, Vol.30 (19), p.2538-2552

2024

Volltextzugriff (PDF)

Lectin‐complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections

Liver international, 2017-07, Vol.37 (7), p.1023-1031

2017

Volltextzugriff (PDF)

IL‐1 receptor antagonist plus pentoxifylline and zinc for severe alcohol‐associated hepatitis

Hepatology (Baltimore, Md.), 2022-10, Vol.76 (4), p.1058-1068

2022

Volltextzugriff (PDF)

Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection

Liver international, 2016-11, Vol.36 (11), p.1628-1638

2016

Volltextzugriff (PDF)

Inhibition of the Inflammasome Signaling Cascade Reduces Alcohol Consumption in Female But Not Male Mice

Alcoholism, clinical and experimental research, 2020-02, Vol.44 (2), p.567-578

2020

Volltextzugriff (PDF)

Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis

Scientific reports, 2018-01, Vol.8 (1), p.399-399, Article 399

2018

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(65)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

The Value of Neutrophil-to-Lymphocyte Ratio to Identify Bacterial Infection and Predict Short-Term Mortality in Patients with Acutely Decompensated Cirrhosis

Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value

Patient‐reported quality of care in primary sclerosing cholangitis

A DNA pool of FLT3-ITD positive DNA samples can be used efficiently for analytical evaluation of NGS-based FLT3-ITD quantitation - Testing several different ITD sequences and rates, simultaneously

Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis

Presepsin teardown- pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis

Emerging medical therapies for severe alcoholic hepatitis

Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study

MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease

Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic Hepatitis

Editorial: serologic antibodies in primary sclerosing cholangitis – a tell‐tale sign of compromised gut‐liver immunity?

Emerging medical therapies for severe alcoholic hepatitis

Serological biomarkers for management of primary sclerosing cholangitis

Sa1676 Soluble CD163 (sCD163) Is a Marker of Infection in Patients With Cirrhosis and Acute Decompensation and an Independent Predictor of the Short-Term Mortality

Neutrophil extracellular traps contribute to liver damage and increase defective low-density neutrophils in alcohol-associated hepatitis

THU-106-YI Prospective european reference network registry (R-LIVER) supports improvement in bone disease care delivery at local level for patients with autoimmune liver diseases and enables detailed description of risk elements

Serum villin-1 level-a tell-tale sign of gut barrier failure in patients with cirrhosis and acute decompensation

OS-017-YI - Serum villin-1 level-a tell-tale sign of gut barrier failure in patients with cirrhosis and acute decompensation

Phenotypic polymorphism of haptoglobin: A novel risk factor for the development of infection in liver cirrhosis

Non-pancreatic hyperlipasemia: A puzzling clinical entity

Lectin‐complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections

IL‐1 receptor antagonist plus pentoxifylline and zinc for severe alcohol‐associated hepatitis

Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection

Inhibition of the Inflammasome Signaling Cascade Reduces Alcohol Consumption in Female But Not Male Mice

Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis

Suchergebnisse filtern